Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle-Reference-Cited by-同舟云学术

Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle

Published:2017-02-28 Issue:5 Volume:66 Page:1172-1184
ISSN:0012-1797
Container-title:Diabetes
language:en
Short-container-title:Diabetes

Author:

O’Brien Tracy P.,Jenkins Erin C.,Estes Shanea K.,Castaneda Antonio V.,Ueta Kiichiro,Farmer Tiffany D.,Puglisi Allison E.,Swift Larry L.,Printz Richard L.,Shiota Masakazu

Funder

National Institute of Diabetes and Digestive and Kidney Disease

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference51 articles.

1. Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913;Ohlson;Diabetologia,1988

2. Postprandial Hyperglycemia and Diabetes Complications

3. Impact of postprandial glucose control on diabetes-related complications: how is the evidence evolving?;Madsbad;J Diabetes Complications,2016

4. SGLT2 inhibitors in the management of type 2 diabetes;Monica Reddy;Endocrine,2016

5. Role of Reduced Suppression of Glucose Production and Diminished Early Insulin Release in Impaired Glucose Tolerance

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in understanding the mechanisms in skeletal muscle of interaction between exercise and frontline antihyperglycemic drugs;Physiological Reports;2024-06

2. The impact of glucagon to support postabsorptive glucose flux and glycemia in healthy rats and its attenuation in male Zucker diabetic fatty rats;American Journal of Physiology-Endocrinology and Metabolism;2024-03-01

3. Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetes;Basic & Clinical Pharmacology & Toxicology;2024-02-26

4. Research Progress of Sodium-Glucose Cotransporter 2 Inhibitor in the Treatment of Polycystic Ovary Syndrome;Advances in Clinical Medicine;2024

5. Antihypertensive Effects of SGLT-2 Inhibitors and Progress in Research;Advances in Clinical Medicine;2024